Orexigenic Therapy With Delta-9-Tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

This study is currently recruiting participants.

Study NCT00316563 Information provided by Alberta Cancer Board

First Received: April 19, 2006 Last Updated: December 4, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2008
Estimated Primary Completion Date:	No date given